Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.
- NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.
- NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_assertion evidence source_evidence_literature NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.
- NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_assertion SIO_000772 19095153 NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.
- NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_assertion wasDerivedFrom befree-20140225 NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.
- NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_assertion wasGeneratedBy ECO_0000203 NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.